Human matrix metalloproteinase-20 (MMP-20, enamelysin) fragments the enamel-specific protein amelogenin and has been shown to be synthesized exclusively by odontoblasts and ameloblasts and in certain odontogenic tumors. Here we demonstrate, for the first time, the expression of MMP-20 mRNA and protein in two carcinoma cell lines originating from the tongue. Treatment of the SCC-25 and HSC-3 cells with phorbol 12-myristate 13-acetate (10 nmol/L) up-regulated MMP-20 mRNA and protein expression by up to 1.6-fold, but transforming growth factor beta (10 ng/mL) had no effect. The latent proform of recombinant (r) human MMP-20 was converted by tumor-related trypsin-2. Activated rMMP-20 did not degrade type I or type II collagen, but efficiently hydrolyzed fibronectin, type IV collagen, laminin-1 and -5, tenascin-C, and (3-casein. This implies that MMP-20 not only participates in dental matrix remodeling but is also present in tongue carcinoma cells.
Bartlett JD, Simmer JP, Xue J., Margolis HC, Moreno EC (1996). Molecular cloning and mRNA tissue distribution of a novel matrix metalloproteinase isolated from porcine enamel organ. Gene183:123-128.
2.
Birkedal-Hansen H., Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B., DeCarlo A., et al. (1993). Matrix metalloproteinases: a review. Crit Rev Oral Biol Med4:197-250.
3.
Caterina J., Shi J., Sun X., Qian Q., Yamada S., Liu Y., et al. (2000). Cloning, characterization and expression analysis of mouse enamelysin. J Dent Res79:1697-1703.
4.
DeCarlo AA Jr, Windsor LJ, Bodden MK, Harber GJ, Birkedal-Hansen B., Birkedal-Hansen H. (1997). Activation and novel processing of matrix metalloproteinases by a thiol-proteinase from the oral anaerobe Porphyromonas gingivalis. J Dent Res76:1260-1270.
5.
Dionisi HM, Checa SK, Viale AM (1995). Protein immunoblotting of stained gels. Biotechniques19:348-350.
6.
Fife RS, Sledge GW Jr (1998). Effects of doxycycline on cancer cells in vitro and in vivo. Adv Dent Res12:94-96.
7.
Fukae M., Tanabe T., Uchida T., Lee SK, Ryu OH, Murakami C., et al. (1998). Enamelysin (matrix metalloproteinase-20): localization in the developing tooth and effects of pH and calcium on amelogenin hydrolysis. J Dent Res77:1580-1588.
8.
Grant GM, Giambemardi TA, Grant AM, Klebe RJ (1999). Overview of expression of matrix metalloproteinases (MMP-17, MMP-18, and MMP-20) in cultured human cells. Matrix Biol18:145-148.
9.
Hamalainen ER, Kemppainen R., Kuivaniemi H., Tromp G., Vaheri A., Pihlajaniemi T., et al. (1995). Quantitative polymerase chain reaction of lysyl oxidase mRNA in malignantly transformed human cell lines demonstrates that their low lysyl oxidase activity is due to low quantities of its mRNA and low levels of transcription of the respective gene. J Biol Chem270:21590-21593.
10.
Hanemaaijer R., Sorsa T., Konttinen YT, Ding Y., Sutinen M., Visser H., et al. (1997). Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-alpha and doxycycline. J Biol Chem272:31504-31509.
11.
Juarez J., Clayman G., Nakajima M., Tanabe KK, Saya H., Nicolson GL, et al. (1993). Role and regulation of expression of 92-kDa type-IV collagenase (MMP-9) in 2 invasive squamous-cell-carcinoma cell lines of the oral cavity. Int J Cancer55:10-18.
12.
Koivunen E., Huhtala M-L., Stenman U-H (1989). Human ovarian tumor-associated trypsin. Its purification and characterization from mucinous cyst fluid and identification as an activator of pro-urokinase. J Biol Chem264:14095-14099.
13.
Koivunen E., Saksela 0, Itkonen 0, Osman S., Huhtala M-L., Stenman U-H. (1991). Human colon carcinoma, fibrosarcoma and leukemia cell lines produce tumor-associated trypsinogen. Int J Cancer47:592-596.
14.
Konttinen YT, Lindy 0, Suomalainen K., Ritchlin C., Saari H., Vauhkonen M., et al. (1991). Substrate specificity and activation mechanisms of collagenase from human rheumatoid synovium. Matrix11:395-403.
15.
Lewalle JM, Munaut C., Pichot B., Cataldo D., Baramova E., Foidart JM (1995). Plasma membrane-dependent activation of gelatinase A in human vascular endothelial cells. J Cell Physiol165:475-483.
16.
Llano E., Pendas AM, Knauper V., Sorsa T., Salo T., Salido E., et al. (1997). Identification and structural and functional characterization of human enamelysin (MMP-20). Biochemistry36:15101-15108.
17.
Palosaari H., Wahlgren J., Larmas M., Ronka H., Sorsa T., Salo T., et al. (2000). The expression of MMP-8 in human odontoblasts and dental pulp cells is down-regulated by TGF-β1. J Dent Res79 :77-84.
18.
Ryu OH, Fincham AG, Hu CC, Zhang C., Qian Q., Bartlett JD, et al. (1999). Characterization of recombinant pig enamelysin activity and cleavage of recombinant pig and mouse amelogenins. J Dent Res78:743-750.
19.
Salo T., Lyons JG, Rahemtulla F., Birkedal-Hansen H., Larjava H. (1991). Transforming growth factor-beta 1 up-regulates type IV collagenase expression in cultured human keratinocytes. J Biol Chem266:11436-11441.
20.
Smith GN Jr, Mickler EA, Hasty KA, Brandt KD (1999). Specificity of inhibition of matrix metalloproteinase activity by doxycycline : relationship to structure of the enzyme. Arthritis Rheum42:1140-1146.
21.
Sorsa T., Ding Y., Salo T., Lauhio A., Teronen 0, Ingman T., et al. (1994). Effects of tetracyclines on neutrophil, gingival, and salivary collagenases. A functional and Western-blot assessment with special reference to their cellular sources in periodontal diseases. Ann NYAcad Sci732:112-131.
22.
Sorsa T., Salo T., Koivunen E., Tyynela J., Konttinen YT, Bergmann U., et al. (1997). Activation of type IV procollagenases by human tumor-associated trypsin-2. J Biol Chem272:21067-21074.
23.
Stracke JO, Fosang AJ, Last K., Mercuri FA, Pendas AM, Llano E., et al. (2000). Matrix metalloproteinases 19 and 20 cleave aggrecan and cartilage oligomeric matrix protein (COMP). FEBS Lett478:52-56.
24.
Takata T., Zhao M., Uchida T., Wang T., Aoki T., Bartlett JD, et al. (2000). Immunohistochemical detection and distribution of enamelysin (MMP-20) in human odontogenic tumors. J Dent Res79:1608-1613.
25.
Teronen 0, Laitinen M., Salo T., Hanemaaijer R., Heikkila P., Konttinen YT, et al. (2000). Inhibition of matrix metalloproteinases by bisphosphonates may in part explain their effects in the treatment of multiple myeloma. Blood96:4006-4007.
26.
Thomas GT, Lewis MP, Speight PM (1999). Matrix metalloproteinases and oral cancer. Oral Oncol35:227-233.
27.
Uitto VJ, Firth JD, Nip L., Golub LM (1994). Doxycycline and chemically modified tetracyclines inhibit gelatinase A (MMP-2) gene expression in human skin keratinocytes. Ann NY Acad Sci732:140-151.
28.
Uria JA, Jimenez MG, Balbin M., Freije Jmp, Lopez-Otin C. (1998). Differential effects of transforming growth factor-beta on the expression of collagenase-1 and collagenase-3 in human fibroblasts . J Biol Chem273:9769-9777.
29.
Xie B., Bucana CD, Fidler IJ (1994). Density-dependent induction of 92-kd type IV collagenase activity in cultures of A431 human epidermoid carcinoma cells. Am J Pathol144:1058-1067.
